[HTML][HTML] HGF/c-Met pathway inhibition combined with chemotherapy increases cytotoxic T-cell infiltration and inhibits pancreatic tumour growth and metastasis

AR Mekapogu, Z Xu, S Pothula, C Perera, T Pang… - Cancer Letters, 2023 - Elsevier
Pancreatic cancer (PC) is a deadly cancer with a high mortality rate. The unique
characteristics of PC, including desmoplasia and immunosuppression, have made it difficult …

Targeting the HGF/c-MET pathway in advanced pancreatic cancer: A key element of treatment that limits primary tumour growth and eliminates metastasis

Z Xu, TCY Pang, AC Liu, SP Pothula… - British Journal of …, 2020 - nature.com
Background Stromal–tumour interactions facilitate pancreatic cancer (PC) progression. The
hepatocyte growth factor (HGF)/c-MET pathway is upregulated in PC and mediates the …

[HTML][HTML] Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer

SP Pothula, Z Xu, D Goldstein, N Merrett, RC Pirola… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Stromal-tumor interactions in pancreatic cancer (PC) impact on treatment outcomes.
Pancreatic stellate cells (PSCs) produce the collagenous stroma of PC and interact with …

Targeting HGF/c-MET axis in pancreatic cancer

SP Pothula, Z Xu, D Goldstein, RC Pirola… - International journal of …, 2020 - mdpi.com
Pancreatic cancer (pancreatic ductal adenocarcinoma (PDAC/PC)) has been an aggressive
disease that is associated with early metastases. It is characterized by dense and …

Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro

J Xu, S Liu, X Yang, S Cao, Y Zhou - Life Sciences, 2020 - Elsevier
Abstract Background Pancreatic stellate cells (PSCs) play key roles in the pancreatic tumor
microenvironment and are considered to contribute to chemoresistance. PSCs can …

Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer

SP Pothula, Z Xu, D Goldstein, AV Biankin… - British journal of …, 2016 - nature.com
Background: Pancreatic stellate cells (PSCs, which produce the stroma of pancreatic cancer
(PC)) interact with cancer cells to facilitate PC growth. A candidate growth factor pathway …

HGF/MET Axis induces tumor secretion of tenascin-C and promotes stromal rewiring in pancreatic cancer

C Modica, M Olivero, F Zuppini, M Milan, C Basilico… - Cancers, 2021 - mdpi.com
Simple Summary It has been previously shown that activation of the MET receptor by its
ligand, the hepatocyte growth factor (HGF), modulates the tumor-stroma cross-talk in models …

HGF/c-MET inhibition as adjuvant therapy improves outcomes in an orthotopic mouse model of pancreatic cancer

TCY Pang, Z Xu, AR Mekapogu, S Pothula, T Becker… - Cancers, 2021 - mdpi.com
Simple Summary Pancreatic cancer (PC) has a poor prognosis. Even though surgical
resection and adjuvant chemotherapy is the most effective therapy, recurrence remains …

[HTML][HTML] Functional heterogeneity in tumor-derived human pancreatic stellate cells: Differential expression of HGF and implications for mitogenic signaling and …

V Tjomsland, M Aasrum, T Christoffersen… - Oncotarget, 2017 - ncbi.nlm.nih.gov
The pancreatic stellate cell (PSC) is the principal cell type of the desmoplastic stroma of
pancreatic ductal adenocarcinoma (PDAC). PSCs interact with cancer cells and influence …

The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell–endothelial cell interactions: antiangiogenic implications in pancreatic cancer

MB Patel, SP Pothula, Z Xu, AK Lee… - …, 2014 - academic.oup.com
Activated cancer-associated human pancreatic stellate cells (CAhPSCs, which produce the
collagenous stroma of pancreatic cancer [PC]) are known to play a major role in PC …